Year-End Report

THE LIVINGSTON GROUP, LLC for PKD FOUNDATION

Period Year-End 2007 Filed Jan 29, 2008

Official filing
Firm
THE LIVINGSTON GROUP, LLC
Client
PKD FOUNDATION
Income
$40,000
Expenses
—

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Medical/Disease Research/Clinical Labs MED

HHS, Defense Appropriations for research and clinical funding for PKD (HR 3043, S 1710; HR 3222); Genetic Information Nondiscrimination Legislation (HR 493; S 358); National PKD Awareness Week Resolution (S. Res. 282); Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2007 (HR 3282, S. 2030); Kidney Care Quality and Education Act of 2007 (HR 1193, S. 691).

LobbyistCovered position, as disclosed
ROBERT L LIVINGSTON N/A
J ALLEN MARTIN N/A

Contacted: Health & Human Services, Dept of (HHS); Natl Institutes of Health (NIH); SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 1193 (110th), H.R. 3282 (110th), S. 2030 (110th), S.Res. 282 (110th), H.R. 493 (110th), H.R. 3222 (110th), H.R. 3043 (110th), S. 691 (110th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.